Bioreference Laboratories an Opko Health Company
Clinical Laboratory
Based in NJ
🤖
AI Overview
With $1.0M in lobbying spend across 26 quarterly filings, Bioreference Laboratories an Opko Health Company is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2019 to 2024.
$1.0M
Total Spend
6
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $175K |
| 2020 | $210K |
| 2021 | $200K |
| 2022 | $250K |
| 2023 | $100K |
| 2024 | $92K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
- •Laboratory Payment
- •Laboratory Regulation
- •Medicare/Medicaid
- •Health Information Technology
- •HR 3107-Prior authorization for payment for genetic testing
- •Regulation of clinical laboratory testing
- •Payment for clinical lab testing/PAMA
- •Regulation of clinical laboratory testing
- •Payment for laboratory testing
- •Prior authorization for genetic testing
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.